Interestingly, IGF2BP2 was upregulated in both transcriptional and protein levels in GCs of PCOS patients (Figure 1A,B), suggesting it was an important regulator to modulate the pathogenesis of PCOS. This evidence concerns the gene IGF2BP2 and polycystic ovary syndrome.